Burning Mouth Syndrome Responsive to Duloxetine: A Case Report

被引:26
作者
Mignogna, Michele D. [1 ]
Adamo, Daniela [1 ]
Schiavone, Vittorio [2 ]
Ravel, Marco Giuseppe [2 ]
Fortuna, Giulio [1 ]
机构
[1] Univ Naples Federico II, Dept Odontostomatol & Maxillofacial Sci, Oral Med Unit, I-80131 Naples, Italy
[2] Univ Naples Federico II, Dept Neurosci, I-80131 Naples, Italy
关键词
BMS; Burning Mouth Syndrome; Duloxetine; Clonazepam; Serotonine; MAJOR DEPRESSIVE DISORDER; REUPTAKE INHIBITOR; DOUBLE-BLIND; EFFICACY; PREVALENCE; MANAGEMENT; SEROTONIN; PLACEBO; PAIN;
D O I
10.1111/j.1526-4637.2010.01035.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Introduction. Burning mouth syndrome (BMS) is a chronic, idiopathic, intraoral mucosal pain condition in the absence of specific oral lesions and systemic disease. Among evidence-based pharmacological treatments for this disorder, topical and systemic clonazepam, levosulpiride, selective serotonine reuptake inhibitors have been used with partial results. Case. We report a case of a 65-year-old otherwise healthy woman with a 3-year history of oral burning. Clinical and laboratory evaluations allowed us to make a diagnosis of burning mouth syndrome. She was treated with duloxetine (60 mg PO qd), a selective serotonine, and norepinephrine reuptake inhibitor, obtaining a complete remission of symptoms, evaluated via standardized clinical rating scales, and an improvement of her quality of life and level of functioning. Discussion. The pathogenesis of BMS still remains unclear. Recently, it has been suggested an underlying neurophatic mechanism, demonstrating a dysfunction in the trigeminal nociceptive pathways at peripheral and/or central nervous system level. The rationale behind the administration of duloxetine resides in its central mechanism of action, and analgesic effects previously demonstrated in diabetic peripheral neurophathy, and fibromyalgia. Also, it has been shown to reduce painful physical symptoms associated with depression. Conclusion. We hypothesize that duloxetine might represent a useful, effective, and additional therapeutic option in the treatment of BMS.
引用
收藏
页码:466 / 469
页数:4
相关论文
共 29 条
[1]   Burning mouth syndrome and psychological disorders [J].
Abetz, L. M. ;
Savage, N. W. .
AUSTRALIAN DENTAL JOURNAL, 2009, 54 (02) :84-93
[2]   Cerebral activation during thermal stimulation of patients who have burning mouth disorder: An fMRI study [J].
Albuquerque, Romulo J. C. ;
de Leeuw, Reny ;
Carlson, Charles R. ;
Okeson, Jeffrey P. ;
Miller, Craig S. ;
Andersen, Anders H. .
PAIN, 2006, 122 (03) :223-234
[3]  
[Anonymous], CLASSIFICATION CHRON
[4]  
[Anonymous], 2005, COCHRANE DATABASE SY
[5]  
Bergdahl M, 1999, J ORAL PATHOL MED, V28, P350
[6]   An open-label study of duloxetine hydrochloride, a mixed serotonin and noradrenaline reuptake inhibitor, in patients with DSM-III-R major depressive disorder [J].
Berk, M ;
duPlessis, AD ;
Birkett, M ;
Richardt, D .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1997, 12 (03) :137-140
[7]   Psychiatric comorbidity in patients with burning mouth syndrome [J].
Bogetto, F ;
Maina, G ;
Ferro, G ;
Carbone, M ;
Gandolfo, S .
PSYCHOSOMATIC MEDICINE, 1998, 60 (03) :378-385
[8]   Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: A Randomized controlled trial [J].
Brecht, Stephan ;
Courtecuisse, Christine ;
Debieuvre, Catherine ;
Croenlein, Jens ;
Desaiah, Durisala ;
Raskin, Joel ;
Petit, Claude ;
Dernyttenaere, Koen .
JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (11) :1707-1716
[9]   Duloxetine for the treatment of major depressive disorder in women ages 40 to 55 years [J].
Burt, VK ;
Wohlreich, MM ;
Mallinckrodt, CH ;
Detke, MJ ;
Watkin, JG ;
Stewart, DE .
PSYCHOSOMATICS, 2005, 46 (04) :345-354
[10]   The dual transporter inhibitor duloxetine: A review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression [J].
Bymaster, FP ;
Lee, TC ;
Knadler, MP ;
Detke, MJ ;
Iyengar, S .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (12) :1475-1493